A Randomized, Open-label Study to Compare Efficacy and S

Project: Research project

Project Details

Description

A Randomized, Open-label Study to Compare Efficacy and Safety of A1001 and Enzyme Replacement Therapy (ERT) in Patients with Fabry Disease and AS1001-Responsive GLA Mutations, Who Were Previously Treated with ERT
StatusFinished
Effective start/end date3/1/136/1/13

Funding

  • Amicus Therapeutics

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.